BME:CIRSA
BME:CIRSAHospitality

Cirsa (BME:CIRSA) Margins Fall to 1.8%, Undercutting Bullish Growth Expectations

Cirsa Enterprises (BME:CIRSA) just posted its Q3 2025 results, revealing revenue of €560.6 million and basic EPS of €0.22. Net income stood at €15.6 million. Looking back, quarterly revenues have moved from €531.5 million in Q3 2024 to €578.7 million last quarter, as reported EPS shifted from a loss of €0.05 in Q4 2024 to €0.26 in Q1 2025. Margins continue to be in the spotlight as investors weigh the company’s profit trajectory against headline growth. See our full analysis for Cirsa...
BME:AEDAS
BME:AEDASReal Estate

Aedas Homes (BME:AEDAS) One-Off Profit Margin Boost Challenges Sustainability Narratives

Aedas Homes (BME:AEDAS) just posted its H1 2026 results, with revenue at €1.2 billion and basic EPS of €3.36 for the trailing twelve months. Looking at recent trends, revenue moved from €914.6 million in H2 2024 to €849.6 million in H2 2025, while EPS has grown from €2.53 to €2.95 over the same periods. Margins held up well, keeping profitability firmly in focus for investors. See our full analysis for Aedas Homes. Next up, we’re stacking these latest numbers against the major narratives...
BME:HBX
BME:HBXHospitality

HBX Group (BME:HBX) Returns to Profit in H2, Challenging Persistent Loss Narrative

HBX Group International (BME:HBX) has just released its FY 2025 financial results, revealing second-half revenue of €401 million and net income of €158 million, with basic EPS coming in at €0.64. The company has seen revenue move from €291 million in FY 2024 H1 to €319 million in FY 2025 H1, and then up again to €401 million in FY 2025 H2. Margins moved sharply through the year, highlighting volatile profitability as HBX continues to balance growth expectations with its bottom line...
BME:TEF
BME:TEFTelecom

Is Telefónica a Bargain After Recent Partnerships and a 3.3% Stock Jump?

Wondering if Telefónica stock is a bargain or just another name on your watchlist? Let’s dig into whether now is a smart time to take a closer look at its value. The stock has had its ups and downs recently, rising 3.3% over the past week but still sitting 6.3% lower year-to-date and trailing with an 8.8% loss over the last 12 months. Recent headlines have focused on Telefónica’s ongoing moves in European telecom markets, including fresh partnerships and network upgrades. These developments...
BME:OHLA
BME:OHLAConstruction

3 European Stocks Possibly Trading Below Their Intrinsic Value By Up To 39.9%

The European stock market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index falling by 2.21% amid concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut. Despite these challenges, business activity in the eurozone continues to expand steadily, presenting potential opportunities for investors seeking stocks that may be undervalued relative to their intrinsic value. In this context, identifying stocks that are trading...
BME:CASH
BME:CASHCommercial Services

Prosegur Cash And 2 European Stocks That Could Be Trading Below Their Estimated Value

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have seen a downturn, with major indices like the STOXX Europe 600 Index ending lower. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to navigate these challenging market conditions effectively.
BME:EDR
BME:EDRHospitality

eDreams ODIGEO (BME:EDR): Assessing Valuation After Guidance Cut and Shifting Growth Outlook

eDreams ODIGEO (BME:EDR) lowered its earnings guidance for 2026 and 2027, citing slower growth in its prime membership base and the effects of a shift toward flexible payment plans for subscribers. See our latest analysis for eDreams ODIGEO. eDreams ODIGEO’s share price has tumbled sharply, down 52% for the month and 59% year-to-date, reflecting fading momentum as investors digest the company’s lower earnings outlook and shifting growth profile. Despite a spike in recent net profit, the...
BME:GRF
BME:GRFBiotechs

Grifols (BME:GRF): Assessing Valuation After a Volatile Year in European Pharma

Grifols (BME:GRF) shares have moved recently, capturing attention after an extended stretch of volatility. Investors are weighing near-term developments as they consider a changing backdrop for the pharmaceutical sector in Europe. See our latest analysis for Grifols. After a turbulent year marked by sharp swings, Grifols’ 8.2% share price return since January stands out, especially as this rise has come despite recent negative momentum, including a 17.3% drop over the last three months and...
BME:SLR
BME:SLRRenewable Energy

Solaria Energía (BME:SLR) Surges After Net Income Jumps on Higher Revenue—Is Profitability the New Growth Engine?

Solaria Energía y Medio Ambiente has released its earnings results for the nine months ended September 30, 2025, reporting €258.91 million in revenue and €141.67 million in net income, both sharply higher compared to the previous year. Despite a slight decline in sales, the company achieved a very large year-on-year increase in net income, highlighting a marked improvement in profitability. We'll examine how Solaria's surge in net income, amid higher revenue, affects the company's investment...